Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PREP | P48147 | 2/20 | 0.31 |
| ▸ | CELA1 | Q9UNI1 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22991501 | 0.92 | — | — | |
| SCHEMBL22991502 | 0.92 | PREP (0.31) | PREPCELA1KDM4ECA2MEN1 | |
| SCHEMBL22991512 | 0.92 | PREP (0.31) | PREPCELA1KDM4ECA2MEN1 | |
| SCHEMBL22991511 | 0.82 | PREP (0.30) | PREPCELA1 | |
| SCHEMBL22991506 | 0.80 | POLB (0.35) | PREPCELA1KDM4EMEN1KMT2A | |
| SCHEMBL22991509 | 0.77 | POLB (0.38) | PREPCELA1KDM4EMEN1KMT2A | |
| SCHEMBL22991508 | 0.74 | POLB (0.36) | PREPCELA1KDM4EMEN1KMT2A | |
| SCHEMBL22991579 | 0.73 | HSD17B10 (0.34) | PREPCELA1KDM4ECA2MEN1 | |
| SCHEMBL22991447 | 0.73 | PREP (0.32) | PREPCELA1KDM4ECA2MAPK1 | |
| SCHEMBL22991507 | 0.73 | POLB (0.35) | PREPCELA1KDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7355067-B2 | Process for the production of triiodotrimesic acid | SCHERING AG (DE) | 2008-04-08 | — | — | US | claimed |
| US-20070093674-A1 | Process for the production of triiodotrimesic acid | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-04-26 | — | — | US | claimed |
| US-7166740-B2 | Process for the production of triiodotrimesic acid | SCHERING AG (DE) | 2007-01-23 | — | — | US | claimed |
| US-20050113598-A1 | Process for the production of triiodotrimesic acid | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2005-05-26 | — | — | US | claimed |
| WO-2021029395-A1 | COMPOUND, POLYMER, COMPOSITION, COMPOSITION FOR FILM FORMATION, PATTERN FORMING METHOD, METHOD FOR FORMING INSULATING FILM, METHOD FOR PRODUCING COMPOUND, IODINE-CONTAINING VINYL POLYMER AND METHOD FOR PRODUCING ACETYLATED DERIVATIVE OF SAME | 三菱瓦斯化学株式会社 | 2021-02-18 | — | — | WO | disclosed |
| US-7355067-B2 | Process for the production of triiodotrimesic acid | SCHERING AG (DE) | 2008-04-08 | — | — | US | disclosed |
| US-20070093674-A1 | Process for the production of triiodotrimesic acid | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-04-26 | — | — | US | disclosed |
| US-7166740-B2 | Process for the production of triiodotrimesic acid | SCHERING AG (DE) | 2007-01-23 | — | — | US | disclosed |
| US-20050113598-A1 | Process for the production of triiodotrimesic acid | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2005-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093674-A1 | Process for the production of triiodotrimesic acid | TRHDE, TRHR, TSHR | PREP 1120/4885CELA1 2435/4885KDM4E 3854/4885 |
| US-20050113598-A1 | Process for the production of triiodotrimesic acid | TRHDE, TRHR, TSHR | PREP 1120/4885CELA1 2435/4885KDM4E 3854/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.